Skip to main content

Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

API Manufacturing Capabilities

Our API manufacturing facilities are operated in accordance with cGMP (ICH Q7) and are regularly inspected/audited by international regulatory authorities and numerous customers. We have eight commercial USFDA inspected production units, from which six production units are in India, and one in Mexico and the UK.


  • 6 manufacturing units
  • Manufacturing capabilities include HPAPI, oncology, and other synthetic molecules


  • Located in Cuernavaca
  • Steroid manufacturing capabilities

United Kingdom

  • Located in Mirfield
  • Manufacturing capabilities include Prostaglandins and PEGylation


Our API manufacturing plants are complemented by formulation manufacturing facilities which can supply a variety of different dosage forms.


Meet our API experts at the world’s
most expansive pharma platform

Join us at CPhI NA 2022!

17th-19th May, 2022 | PCC, PHL
Schedule a meeting